Peripheral and central antinociceptive actions of ethylketocyclazocine in the formalin test.
The antinociceptive actions of ethylketocyclazocine and morphine were examined in rats in a thermal nociceptive test (tail-immersion) and a test involving minor tissue injury (formalin). In the formalin test, the antinociceptive effects of high doses of ethylketocyclazocine, but not morphine, were attenuated by the peripherally acting antagonist naloxone methylbromide. Naloxone methylbromide had no effect on antinociception produced by ethylketocyclazocine in the tail-immersion test. When ethylketocyclazocine was injected intraventricularly, only partial antinociception was observed in the formalin test. Conversely, naloxone given intraventricularly only partially attenuated the antinociception produced by ethylketocyclazocine given systemically. The data indicate that the antinociceptive effects of ethylketocyclazocine in the tissue injury-induced nociception are a result of summation of central and peripheral actions. Morphine antinociception reaches ceiling at doses that are devoid of such peripheral actions. The data imply that it may be possible to develop a new class of peripherally acting analgesics that are effective in acute inflammatory pain.
Abbott
F V
FV
School of Nursing, McGill University, Montreal, Quebec, Canada.
D000700:Analgesics; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003496:Cyclazocine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D016314:Ethylketocyclazocine; D005557:Formaldehyde; D007276:Injections, Intraventricular; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy*; D051381:Rats
D000700:Analgesics; D000701:Analgesics, Opioid; D005557:Formaldehyde; D009270:Naloxone; D016314:Ethylketocyclazocine; D003496:Cyclazocine